Physician profile
Brandon Nguyen
NPI 1508882564
$2,163.07
in general payments reported to CMS, 2019-2025
13 companies · $41.37 in 2025
The $41.37 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2021: $50.58 · 2022: $646 · 2023: $778 · 2024: $171 · 2025: $41.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727 · Travel and Lodging: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.29 |
| Travel and Lodging | $262.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $655.01 | 2019-2023 | Proclaim |
| Nevro Corp. | $597.24 | 2019-2023 | Senza |
| Spinal Simplicity, LLC | $337.47 | 2023 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $159.15 | 2023 | Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $117.02 | 2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $80.17 | 2022-2025 | Belbuca |
| Stryker Corporation | $69.67 | 2019 | |
| Convatec INC. | $37.79 | 2024 | |
| Hikma Pharmaceuticals USA | $32.68 | 2022 | |
| Si-Bone, INC. | $31.38 | 2022 | |
| Abbvie INC. | $17.07 | 2023 | |
| Saluda Medical Americas, INC. | $15.97 | 2024 | Evoke |
| Biodelivery Sciences International, INC. | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.